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Abstract
Irreversible electroporation (IRE) is a non-thermal ablation 
technique used especially in locally advanced pancreatic 
carcinomas that are considered surgically unresectable. 
We present the first case of acute superior mesenteric 
artery (SMA) occlusion secondary to pancreatic IRE 
procedure that has not been reported before in the 
literature. A 66-year-old man underwent neoadjuvant 
chemoradiotherapy for locally advanced pancreatic 
ductal adenocarcinoma. IRE procedure was applied to 
the patient during laparotomy under general anesthesia. 
After finishing the procedure, an acute intestinal ischemia 
was detected. A conventional vascular angiography was 
performed and a metallic stent was successfully placed to 
the SMA and blood flow was maintained. It is important 
to be careful in such cases of tumor involvement of SMA 
when evaluating for IRE procedure of pancreatic tumor.
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Core tip: Irreversible electroporation (IRE) is a non-
thermal ablation technique is a hope for patients 
who have unresectable locally advanced pancreatic 
carcinomas; especially, when any vascular surgical 
approach is impossible because of the tumor involvement. 
We encountered superior mesenteric artery occlusion 
after IRE procedure for locally advanced pancreatic 
cancer. We suggest that treating physicians should keep 
in mind that kind of mortal vascular complications of IRE. 
Stent placement via  angiography could be the lifesaving 
treatment choice for vascular occlusions due to IRE 
procedure. 
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INTRODUCTION
The majority of the pancreatic adenocarcinomas are 
diagnosed at an advanced stage, with resectable tumors 
being identified in only 10%-20% of the cases at the 
time of first admission[1]. Involvement of the celiac trunk, 
superior mesenteric artery or portal vein without distant 
metastasis is observed in 40% of cases with stage 3 
disease[2,3]. For these patients, a 5-year survival rate of 
6.8% has been reported following surgical resection[4]. 
These patients are now classified as locally advanced 
stage pancreatic cancer (LAPC), and their survival rates 
are reportedly better compared to patients with distant 
metastasis. The probability of surgical resection following 
neoadjuvant treatment is higher in these patients[5]. 
Nowadays, different ablation techniques are being studied 
in combination with neoadjuvant treatment[6]. Some 
thermal ablation techniques such as radiofrequency 
ablation (RFA), cryoablation and microwave ablation 
have been developed and defined for tumor ablation. 
Thermal ablation methods are reported to cause necrosis 
during treatment for LAPC through thermal injury in the 
peripancreatic fatty tissue, main vascular structures, 
pancreatic tissue, duodenum and biliary tract[7]. These 
morbid complications are limitations of these techniques 
for pancreatic tumors.
Irreversible electroporation (IRE) creates pores in cell 
membrane by transmitting short electrical currents at 
high voltage[8]. As a result, the phospholipid membrane 
of the cell is permanently damaged, and the apoptosis 
and necrosis complex is observed due to the impairment 
of cellular homeostasis. Since IRE is not a thermal 
ablation technique, it is assumed that it is affected to 
a lesser extent from the vascular flow surrounding the 
tissue[9]. No decrease in ablation energy is observed, due 
to the effect on the main vascular blood flow. Also, due to 
the shorter duration of treatment, a larger affected tissue 
volume, and a lower pain response, this technique is 
considered to be superior to other ablation techniques[10]. 
Previous studies demonstrated that IRE use in the 
treatment of locally advanced pancreatic cancer was 
safe, since it resulted in no harm to the peripancreatic 
tissues and did not affect the superior mesenteric artery, 
porta hepatis and biliary tract[11]. Metallic stent removal 
is recommended prior to the use of IRE in cases where 
a metallic stent is applied in the biliary tract for biliary 
obstruction. It is believed that the presence of a metallic 
stent in the field of electrical flow within the duodenum 
may result in damage to the adjacent structures [12]. 
Studies conducted in various centers around the 
world have reported the short and long term protocol 
of IRE to be effective in the treatment of LAPD. In these 
studies no important morbid complication was reported 
like SMA occlusion. However, in this case report, we 
draw attention to a previously unpublished complication 
of IRE in LAPC.
CASE REPORT
A 66-year-old man with locally advanced pancreatic head 
adenocarcinoma diagnosed by fine-needle aspiration 
biopsy 6 mo ago was admitted to our institution. Tumor 
markers were measured, with CA 19-9 = 4801 IU/mL 
and CA 125 = 161 IU/mL. After diagnosis, a plastic stent 
was placed in ductus choledocus with ERCP. Immediately 
afterwards, chemoradiation was administered to the 
patients [5 cycles of chemotherapy consisting of Folfox + 
5-FU + Oxaliplatin every 14 d, for 28 d RTA (28 fractions 
50, 4 gray IMRT received)]. After admission to our 
hospital, computerized tomography (CT) examination 
was performed to the patient, and a malignant mass 
of 45 mm in diameter was observed at the pancreatic 
head level (Figure 1). It was noted that the tumor had 
surrounded the superior mesenteric artery 360 degrees, 
the affected segment of SMA was 40 mm. The tumor 
had apparently reduced the SMA diameter by 3 mm 
(Figure 1). Main pancreatic duct was markedly dilated, 
and the diameter was measured as approximately 7 
mm. There was no metastasis and the tumor was stable 
after neoadjuvant chemotherapy. 
The patient was referred to our hospital with a dia-
gnosis of LAPC. Irreversible electroporation for pancreatic 
tumor and simultaneous gastrojejunostomy was planned. 
The abdomen was opened with a median incision above 
the umbilicus and abdominal exploration was performed. 
During the exploration, no distant metastases were 
identified anywhere in the abdomen. Intraoperative liver 
ultrasonography was used to detect possible metastasis 
to liver. The patient was under general anesthesia, 
surgery was performed in the supine position. The 
gastro-colic omentum was opened to reach and expose 
the pancreatic tumor. Electroporation was performed in 
accordance with the procedural instructions.
Figure 1  Coronal plain computerized tomography. Locally advanced 
pancreatic malignant mass of 45 mm in diameter surrounded and narrowed 
superior mesenteric artery (arrow).
753 October 15, 2016|Volume 8|Issue 10|WJGO|www.wjgnet.com
IRE was performed using the Nanoknife System 
(Angiodynamics, Lanthan), as described in the previous 
manuscript on IRE for the pancreas. High definition 
intraoperative ultrasound imaging was used in all 
cases, which is required to demonstrate non-traumatic 
precise needle placement and also for continuous 
ablation assessment during IRE. In sum, 3 monopolar 
probes with 2-cm spacing will deliver an electroporation 
defect of approximately 3.5 cm axial, 2.5 cm anterior-
posterior, and 2.5 cm cranial-caudal. This electroporation 
procedure is achieved through a maximum of 1.5 cm 
exposure, 1500 V/cm, and 100 s wavelength. The 
procedure was performed in 45 min. After IRE procedure 
a gastrojejunostomy completed. After completing 
gastrojejunostomy anastomosis, a color change was 
concurrently observed in the small intestine. Based on a 
suspicion of SMA occlusion, arterial pulse was checked 
in the small bowel mesentery. No pulse was obtained 
in this area. The abdomen of the patient was closed, 
and he was taken to the angiography unit because SMA 
occlusion developed in the tumor surrounded segment. 
In angiography images, it was observed that a short 
segment after the origin of SMA, right hepatic artery 
was arising. Even after 1 cm distal to right hepatic artery 
origin there was no blood flow in the SMA (Figure 2). 
First of all, occluded segment was dilated with a 3 mm 
balloon. After dilatation a 4 mm and 3 cm length metallic 
stent was placed to this dilated segment (Figure 3). 
There were no complications in the postoperative follow-
up. The patient was discharged without any complication 
the sixth day postoperatively.
DISCUSSION
Nearly 30% to 40% of patients with pancreatic adeno-
carcinoma have a locally advanced disease with stage III 
at the time of diagnosis and half of the tumors involved 
celiac axis and SMA. Autopsy studies have demonstrated 
that 30% of the patients with pancreatic cancer are in 
locally advanced stage with no distant metastasis[13]. 
Chemoradiotherapy used in the conventional treatment 
of such patients is of limited efficacy. In the past, 
hepaticojejunostomy or gastrojejunostomy were 
commonly used in the palliative surgical treatment of 
patients with LAPC. IRE is a new hope for the patients’ 
with LAPC in locally control of pancreatic cancer with 
survival benefits. We perform IRE for LAPC invaded or 
encapsulated superior mesenteric artery in the absence 
of distant metastasis. We perform 3 to 5 per annually 
IRE since 2013 in our institution. 
In the classical surgical approach, pancreatico-
duodenectomy (PD) is preferred in resectable pancreatic 
carcinomas. Although acute occlusion or thrombosis 
in the hepatic artery, portal vein, SMA or celiac artery 
are rarely observed following this operation, they 
are still considered as the most significant causes of 
mortality. Gaujoux et al[14] preoperatively evaluated 545 
patients who underwent PD, by arterial reconstruction, 
examining SMA and celiac artery stenosis with CT, 
and detecting hemodynamically significant stenosis 
is 27 (5%) of the patients. On the other hand, five 
patients died due to undetectable stenosis and ischemic 
complications. Stent placement and bypass procedures 
were preoperatively performed in those patients, with 
an effort being made to prevent postoperative ischemic 
complications. Overall, the rate of complications was 
reported as 2.6%. It was observed that 36% of these 
complications were ischemic complications associated 
with undetectable stenosis[14]. Other studies in the 
literature recommend the application of CT, angiography 
or intraoperative Doppler ultrasonography, and clamping 
the gastroduodenal artery for the diagnosis of SMA 
occlusion[15]. Median arcuate ligament compression, 
atherosclerotic stenosis or fibromuscular dysplasia and 
tumor involvement of SMA might be the cause of acute 
occlusion of SMA in patients with pancreatic cancer[16]. 
Recommended treatment modalities in acute SMA 
occlusion include thrombectomy, revascularization with 
side-to-side or end-to-side anastomosis, and stent 
application by angiography[17]. While SMA occlusion 
is rarely observed during PD, acute SMA occlusion 
has never been previously reported in the literature 
Figure 2  Conventional angiography of superior mesenteric artery 
immediately after irreversible electroporation. Angiography revealed that 
there is occlusion in superior mesenteric artery (red arrow) and also occlusion 
in hepatic artery (white arrow) originated from superior mesenteric artery. 
Figure 3 Conventional angiography of superior mesenteric artery after 
stent placement. After the stent placement superior mesenteric artery re-
canalized and intestinal blood flow was maintained (arrow shows the re-
canalized superior mesenteric artery).
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in patients who underwent IRE. The impaired blood 
supply in the jejunal segments, which was noticed 
intraoperatively in our case presented here, enables 
the detection of SMA occlusion. Since access to the 
occluded segment in our case would be easier by 
vascular angiography, stent placement was preferred 
for treatment choice. Accessing the SMA surgically, 
on the other hand, was not possible because of tumor 
involvement. Therefore, by using angiography, diagnosis 
and treatment were both performed at the same time. 
Owing to the imaging techniques used today, LAPC 
can be diagnosed preoperatively. Endoscopically applied 
biliary and/or duodenal stents provide a chance for 
palliative treatment by eliminating the risk of surgical 
morbidity for the patient[18]. Currently defined thermal 
ablation techniques are known to be inefficient for 
adequate ablation of tumor cells adjacent to vascular 
structures due to the heat sink effect. IRE provides 
non-thermal ablation in tumor cells through the short 
electrical currents with high amplitude. Therefore, it 
can be applied in LAPC without being affected from the 
flow in portal vein, celiac artery, biliary tract or SMA. 
However, IRE modulates vascular smooth muscle 
cells to apoptosis; but it has been demonstrated that 
elastin and collagen in particular, which are present 
in vascular structures, have been affected from this 
ablation technique[19]. After IRE blood flow is intact and 
vascular smooth muscle cells repopulate in a short time 
period[19]. The method’s efficacy was demonstrated 
in studies performed on large tumor areas, where 
its application was associated with shorter times and 
lesser complications. Folfirinox or gemcitabine based 
chemotherapy is used for approximately 4 mo in the first 
line treatment of LAPC, and its efficacy is approved by 
the National Comprehensive Network Guideline[20]. 
In a study by Martin et al[21], 54 patients who 
underwent IRE were compared with 85 patients who 
were admitted for standard chemotherapy. At the end 
of the study, no significant differences were found in 
overall survival and progression-free survival between 
patients who underwent systemic chemotherapy for 4 
mo and who underwent IRE treatment[21]. The overall 
survival results of the IRE applied to 200 patients 
revealed no significant differences with patients 
receiving chemoradiotherapy and it was recommended 
that chemoradiotherapy, is used along with IRE as 
part of a triple treatment protocol. In this multicenter 
study, minor complications were observed among those 
200 patients, but no case of acute vascular occlusion 
was encountered[22]. Other studies with large series 
demonstrated that application of IRE was safe and 
efficient around vascular structures[23].
Unexpected complications are being reported as 
clinical studies are continuing. Following application of 
this technique, various complications have been reported 
secondary to electrical transmission, especially in patients 
with metallic biliary stents or enteric stents[12].
In the review of the literature, we did not encounter 
any study on SMA occlusion following IRE application, as 
was the case with our patient presented herein. A recent 
systematic review reported an IRE-related complication 
rate of 13%, with an IRE-related mortality of 2%[24]. 
Martin et al[22], in a recent study with a population of 200 
patients suffering from LAPC treated with IRE, showed 
an overall rate of adverse events of 37% (74 patients 
with 149 overall complications) and a mortality rate of 
2%. The most common complications (including both 
percutaneous and open techniques) described after the 
use of IRE on pancreas are pancreatitis, pneumothorax, 
hematoma, abdominal pain, bile leakage, pancreatic 
leakage, duodenal leakage, duodenal ulcer, deep vein 
thrombosis/pulmonary embolism and superior me-
senteric venous occlusion.
In healthy individuals average diameter of SMA was 
reported between 7.3 and 5.9 mm[24]. The measured 
diameter of SMA in this case with CT scan was 3 
mm. The tumor involved the artery and decreased its 
diameter nearly 50%. After the IRE procedure edema 
may developed around the ablation area or at the wall 
of the artery may especially cause an SMA occlusion. 
SMA occlusion and intestinal ischemia was noticed 
earlier in the present case, since IRE was applied 
simultaneously with open surgery, and this condition 
was treated by an angiographically applied vascular 
stent before necrosis developed in the jejunal segments. 
It is more important to be careful in percutaneous IRE 
procedures for LAPC because it is difficult to diagnose 
intestinal ischemia such a short time period. 
The anatomy of the hepatic artery varies sub-
stantially. Reported rate of replaced right hepatic artery 
from SMA ranges from 5% to 25%[25]. A variant artery 
is an important risk factor when the surgeon unaware of 
this anomaly. It is possible to progress the thrombosis 
to the stump of right hepatic artery in such cases. This 
is another possible fatal complication of SMA occlusion 
when hepatic artery arises from SMA. The liver and gut 
will become necrotic within a few hours. 
Recently, percutaneous IRE application has been 
tried and its results in terms of overall survival were 
observed to be positive[26]. Placement of probes could 
be both percutaneous and surgical; it depends on 
localization of the lesion and experience of the team. 
One should pay attention to acute vascular occlusions 
that might develop in such cases. It is also necessary 
to bear in mind that acute vascular occlusions might 
develop during percutaneous or surgical IRE application 
in LAPC.
IRE expands the scope of treatment of lesions that 
is near to major vascular/biliary/urinary structures. 
Because of this adjacency, these lesions are not suitable 
for local ablative therapies and could only be try to treat 
with some forms of external beam radiation therapy. 
In order to prevent injury of these major structures 
by displacement of electrodes, there is a need for 
general anesthesia (deep paralysis)[23]. The only 
contraindication of IRE is patients with pacemakers or 
with cardiac arrhythmias[27]. IRE is mostly applied for 
locally advanced tumors invaded to adjacent structures. 
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As in our case, if there is a severe vascular invasion 
is decreasing the diameter more than 50%, a coated 
vascular stent could be placed to the narrowed segment 
before applying IRE.
In conclusion, we present a new and fatal com-
plication of IRE procedure for LAPC. In our patient, 
the diameter of SMA was decreased over 50% when 
compared with a healthy individuals SMA. We think that 
both arterial narrowing and IRE depend tissue edema 
are affective factors for acute SMA occlusion. However, 
it might also be speculated that the monopolar probes 
itself caused direct SMA injury or induced, e.g., a 
small hematoma in the vicinity of the SMA, resulting in 
occlusion of the already narrowed vessel. 
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